Medindia

X

Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

Wednesday, October 31, 2007 General News J E 4
Advertisement
VIENNA, Va., Oct. 31 Modigene Inc.(OTC Bulletin Board: MODG) today announced that senior management will presentat the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference onWednesday, November 7, 2007 at 1:40 pm ET. The conference will be held at theNew York Palace Hotel in New York City.

Modigene CEO Abraham Havron and President Shai Novik will attend.Management will provide a company overview and review of corporatedevelopments.

The presentation will be webcast live and can be accessed by visiting theInvestors section of the Modigene website at www.modigeneinc.com. An archivedversion of the webcast will be available for approximately 90 days. The liveand archived webcast can also be accessed atwww.wsw.com/webcast/rrshq12/modg.ob.

For more information about this conference, visit:www.rodmanandrenshaw.com/conferences?id=6

About Modigene

Modigene Inc. is a biopharmaceutical company applying its patented CTPtechnology to develop longer-acting, proprietary versions of already approvedtherapeutic proteins that currently generate billions of dollars in annualglobal sales. The CTP technology is applicable to virtually all proteins andModigene is currently developing long-acting versions of human growth hormone,interferon beta and erythropoietin, which are in late preclinical development,as well as GLP-1. For more information on Modigene, visitwww.modigeneinc.com.MODIGENE CONTACT: MEDIA CONTACT: Shai Novik, President Barbara Lindheim Modigene Inc. GendeLLindheim BioCom Partners Tel: +1 866 644-7811 +1 212 918-4650 Email: shai@modigeneinc.com

SOURCE Modigene Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Genta Incorporated to Present at the Acumen BioFin...
S
Arena Pharmaceuticals to Present at the Acumen Bio...